Results 211 to 220 of about 11,852,880 (383)

Annual 12‐Week Dosing Gap of Natalizumab: Clinical Efficacy, Blood Biomarkers, and CSF Cell Composition

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Natalizumab (NTZ) is a highly effective therapy for multiple sclerosis (MS); however, its use is limited by the risk of a rare potentially severe opportunistic brain infection, progressive multifocal leukoencephalopathy (PML). Alternative dosing strategies are evaluated to reduce PML risk while still maintaining efficacy, which ...
Regina Berkovich   +10 more
wiley   +1 more source

Multimodality Fusion Aspects of Medical Diagnosis: A Comprehensive Review. [PDF]

open access: yesBioengineering (Basel)
Kumar S, Rani S, Sharma S, Min H.
europepmc   +1 more source

Exosome Proteomics of SOD1D90A Mutation Suggest Early Disease Mechanisms, and FN1 as a Biomarker

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Amyotrophic lateral sclerosis (ALS) is a neuromuscular disease. Super oxide dismutase 1 (SOD1) gene mutations cause ALS, and the D90A mutation is associated with primarily upper motor neuron (UMN) loss. Objective Our goal is to reveal the early cellular events in ALS pathology and identify potential pharmacokinetic biomarkers, using well ...
Mukesh Gautam   +6 more
wiley   +1 more source

Reducing the workload of medical diagnosis through artificial intelligence: A narrative review. [PDF]

open access: yesMedicine (Baltimore)
Jeong J   +9 more
europepmc   +1 more source

The challenge of cognitive science for medical diagnosis. [PDF]

open access: yesCogn Res Princ Implic, 2023
Croskerry P, Campbell SG, Petrie DA.
europepmc   +1 more source

Home - About - Disclaimer - Privacy